The landscape for weight-loss and diabetes treatment shifted dramatically over the weekend as at least six Indian pharmaceutical companies introduced generic versions of Novo Nordisk A/S’ (NYSE:NVO) b[...]
Read moreArticles written by Vandana Singh
Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs
Eli Lilly and Co. (NYSE:LLY) stock is trading higher after the company released better-than-expected Q4 earnings and issued fiscal 2026 guidance. Earnings Overview Eli Lilly reported fourth-quarter ad[...]
Read moreFDA Strikes Off European Biotech Pharming’s Immune Deficiency Drug for Expanded Use in Pediatric Patients
The U.S. Food and Drug Administration (FDA) on Friday issued a Complete Response Letter (CRL) to Pharming Group’s (NASDAQ:PHAR) supplemental New Drug Application (sNDA) for Joenja (leniolisib) for chi[...]
Read moreJohnson & Johnson Wins FDA Nod for First Precision Combo for Mutated Prostate Cancer
On Friday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE:JNJ) supplemental New Drug Application (sNDA) for Akeega (niraparib and abiraterone acetate) plus pr[...]
Read more